Načítá se...
The Promises and Pitfalls of Reboxetine
The antidepressant compound, morpholine, 2‐[(2‐ethoxyphenoxy)phenylmethyl]‐, methanesulfonate, or reboxetine, is a selective noradrenergic reuptake inhibitor that acts by binding to the norepinephrine (NE) transporter and blocking reuptake of extracellular NE back into terminals. This compound has l...
Uloženo v:
| Vydáno v: | CNS Drug Rev |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Blackwell Publishing Ltd
2006
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6741698/ https://ncbi.nlm.nih.gov/pubmed/14647527 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1527-3458.2003.tb00258.x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|